FDA approves groundbreaking new pancreatic cancer drug
Summary
The FDA approved a new medicine called daraxonrasib for people with advanced pancreatic cancer. This pill is taken once a day and offers a new treatment option for patients with this deadly disease.Key Facts
- The FDA gave approval for daraxonrasib on Wednesday.
- Daraxonrasib targets advanced pancreatic cancer.
- The medicine is a daily pill.
- It is made by Revolution Medicines.
- The brand name for daraxonrasib is Rasonque.
- The drug is for patients who have already tried other treatments.
- Pancreatic cancer is known to be very aggressive and hard to treat.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
